TBC
BMY icon

Ted Buchan & Co’s Bristol-Myers Squibb BMY Stock Holding History

Ted Buchan & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
32,055
+155
+0.5% +$8.9K 0.6% 36
2026
Q1 		$1.93M Buy
31,900
+221
+0.7% +$12.9K 0.7% 33
2025
Q4 		$1.71M Buy
31,679
+2,068
+7% +$99.5K 0.63% 36
2025
Q3 		$1.34M Buy
29,611
+2,386
+9% +$111K 0.52% 44
2025
Q2 		$1.26M Buy
27,225
+3,888
+17% +$191K 0.5% 45
2025
Q1 		$1.42M Sell
23,337
-360
-2% -$21K 0.67% 31
2024
Q4 		$1.34M Buy
23,697
+1,440
+6% +$80.5K 0.63% 33
2024
Q3 		$1.15M Buy
+22,257
New +$1.04M 0.55% 35

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ted Buchan & Co's BMY Position: Q2 2026 in Review

Ted Buchan & Co increased its Bristol-Myers Squibb (BMY) stake by 0.49% in Q2 2026, buying an estimated $8.9K and bringing the position to 32,055 shares worth $1.85M. The position accounts for 0.6% of the portfolio, ranked #36.

Ted Buchan & Co first reported a position in BMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.93M in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Ted Buchan & Co held 32,055 shares of Bristol-Myers Squibb worth $1.85M as of Q2 2026.
  • Ted Buchan & Co bought 155 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.9K.
  • Bristol-Myers Squibb made up 0.6% of Ted Buchan & Co's portfolio in Q2 2026, its #36 holding.
  • Ted Buchan & Co first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 8 quarters since.
  • Ted Buchan & Co's Bristol-Myers Squibb position peaked at $1.93M in Q1 2026.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ted Buchan & Co's 13F filing for Q2 2026, filed 23 Jul 2026.